Recent years have witnessed explorations into the roles of novel biomarkers, including meteorin-like protein (Metrnl), also known as subfatin, and zonulin, in PCOS development, progression, and interconnected metabolic disturbances. This evidence concerns the gene HP and polycystic ovary syndrome.